Clinical Trial Update: Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

View source ↗

Summary

A completed 12-month surveillance study assessing long-term use of sodium risedronate tablets (Benet 75 mg) for osteoporosis with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Benet 75 mg tablets (sodium risedronate)

Snippet

Sponsor: Takeda | Conditions: Osteoporosis | Status: COMPLETED | Results posted: 2018-10-19